Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Red River Biorefinery was a U.S. advanced ethanol production company operating a commercial biorefinery in Grand Forks, North Dakota. The facility used agricultural byproducts such as sugar beet tailings, potato waste, and pasta waste to produce fuel-grade ethanol, USP-grade ethanol for sanitizers and disinfectants, renewable natural gas, and animal feed. The business was positioned as a low-carbon, waste-to-biofuels operation rather than a therapeutics or healthcare company, although it supplied pharmaceutical-grade ethanol as an ingredient for hygiene products during the COVID-19 period. Available third-party sources indicate the company operated privately and was later listed as closed. It does not appear to have a drug development pipeline or clinical programs.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Red River Biorefinery.